Journal of Pediatric Epilepsy 2020; 09(01): 018-021
DOI: 10.1055/s-0040-1701240
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Ictal Bradyarrhythmia in a 2-Year-Old Male with Brainstem Embryonal Tumor

1   Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
2   Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States
,
1   Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
2   Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States
,
1   Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
2   Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States
› Author Affiliations
Further Information

Publication History

01 November 2019

24 December 2019

Publication Date:
24 January 2020 (online)

Abstract

Ictal bradyarrhythmia can be challenging to diagnose when motor features of seizures are absent. Associated bradycardia can involve periods of asystole requiring cardiac pacemaker placement. Here, we report a 2-year-old male with a brainstem embryonal tumor with more than 30 seizures per day manifesting as bradycardia, loss of tone, and decreased responsiveness, followed by vomiting. Associated electrographic changes were localized to the right temporal head region, where the patient's tumor exerted mass effect. The patient was treated with lacosamide at higher doses than previously reported (24 mg/kg/d) and became seizure-free on a combination of this medication with clobazam. Oral albuterol was also used to augment his heart rate as the patient was not a candidate for cardiac pacemaker insertion.

 
  • References

  • 1 Baumgartner C, Koren J, Britto-Arias M, Schmidt S, Pirker S. Epidemiology and pathophysiology of autonomic seizures: a systematic review. Clin Auton Res 2019; 29 (02) 137-150
  • 2 Janszky J, Fogarasi A, Toth V. , et al. Peri-ictal vegetative symptoms in temporal lobe epilepsy. Epilepsy Behav 2007; 11 (01) 125-129
  • 3 Duplyakov D, Golovina G, Lyukshina N, Surkova E, Elger CE, Surges R. Syncope, seizure-induced bradycardia and asystole: two cases and review of clinical and pathophysiological features. Seizure 2014; 23 (07) 506-511
  • 4 Giovannini G, Meletti S. Ictal asystole as the first presentation of epilepsy: a case report and systematic literature review. Epilepsy Behav Case Rep 2014; 2: 136-141
  • 5 Bartlam R, Mohanraj R. Ictal bradyarrhythmias and asystole requiring pacemaker implantation: combined EEG-ECG analysis of 5 cases. Epilepsy Behav 2016; 64 (Pt A): 212-215
  • 6 Schuele SU, Bermeo AC, Alexopoulos AV. , et al. Video-electrographic and clinical features in patients with ictal asystole. Neurology 2007; 69 (05) 434-441
  • 7 Chouchou F, Mauguière F, Vallayer O. , et al. How the insula speaks to the heart: cardiac responses to insular stimulation in humans. Hum Brain Mapp 2019; 40 (09) 2611-2622
  • 8 Dylgjeri S, Taussig D, Chipaux M. , et al. Insular and insulo-opercular epilepsy in childhood: an SEEG study. Seizure 2014; 23 (04) 300-308
  • 9 Sirin NG, Gurses C, Bebek N, Dirican A, Baykan B, Gokyigit A. A quadruple examination of ictal EEG patterns in mesial temporal lobe epilepsy with hippocampal sclerosis: onset, propagation, later significant pattern, and termination. J Clin Neurophysiol 2013; 30 (04) 329-338
  • 10 Casas-Fernández C, Martínez-Bermejo A, Rufo-Campos M. , et al. Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain. Drugs R D 2012; 12 (04) 187-197
  • 11 McGinnis E, Kessler SK. Lacosamide use in children with epilepsy: retention rate and effect of concomitant sodium channel blockers in a large cohort. Epilepsia 2016; 57 (09) 1416-1425
  • 12 Ortiz de la Rosa JS, Ladino LD, Rodríguez PJ, Rueda MC, Polanía JP, Castañeda AC. Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: a systematic review. Seizure 2018; 56: 34-40
  • 13 Italiano D, Perucca E. Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age: an update. Clin Pharmacokinet 2013; 52 (08) 627-645
  • 14 Farkas V, Steinborn B, Flamini JR. , et al; SP0969 Study Group. Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures. Neurology 2019; 93 (12) e1212-e1226